Biotech

All Articles

Gene publisher Volume laying off 131 employees

.Just days after gene editor Volume Biosciences announced secret functional slices, a clearer photo ...

Repare lays off 25% of team as biotech stops preclinical R&ampD

.Repare Therapy is actually giving up a fourth of its own labor force as the oncology biotech downsi...

J &amp J files for FDA approval of $6.5 B autoimmune drug

.Johnson &amp Johnson has taken one more measure toward realizing a return on its $6.5 billion nipoc...

Gain's period 1 gain leads means to prove Parkinson's drug's worth

.Gain Therapies has actually set its sights on showing the effectiveness of its Parkinson's ailment ...

Actinogen documents brand new phase 2 data to recover clinical depression medicine

.Actinogen Medical's chances-- as well as inventory price-- have actually rebounded slightly from pr...

Pfizer and also Main add Quotient to multibillion-dollar equation

.Crown Jewel Pioneering and Pfizer have actually added Ratio right into their 10-program relationshi...

Bayer pens $547M treaty to push borders of noncoding RNA

.Bayer executives were interested to stress and anxiety to Tough this summer that the German pharma ...

UK reveals programs to introduce 18 brand new clinical trial centers

.Surrounded by a yearslong professional trial decrease in the U.K., a brand-new public-private partn...

UPDATE: Genentech telegraphs 93 discharges in The golden state after sharing plannings to shutter cancer cells immunology study system

.Following the statement of a large unemployment shot in April as well as a major rebuilding effort ...

Neurocrine's KarXT competitor hits in period 2-- yet only at low dose

.Neurocrine Biosciences has actually achieved its own hoped-for profile page in a stage 2 mental ill...